Displaying 1–25 of 770 results for
Biosimilar commercialization challenges, real-world tips for updating aging facilities and a deep dive into interchangeability guidance.
How slow-motion trends are driving biopharma growth, the dangerous impact of unproven stem cell therapies and more.
Today’s developing environment — coined the Fourth Industrial Revolution and characterized by rapidly evolving and disruptive advances in technology — has created a new and intimidating landscape. In order to propel itself into the next stage of digital transformation, pharma needs to confront ...
Discover recently launched or updated technologies and systems that have changed the game in pharmaceutical manufacturing including high-quality equipment in various fields.
Despite the increasing number of injectable biologics, solid dose products are a proven pharmaceutical market mainstay.
It’s not too late for the pharmaceutical industry to dodge its reputation for being behind other industries in terms of adopting technology.
As the industry invests in serialization capabilities to ensure regulatory compliance, they have the opportunity to explore how serialization can be used to develop new processes and capabilities.
the results and analysis of a recent industry survey indicating the need for an integrated, systematic approach to corrective and preventative action.
Industry survey indicates pharma’s need to move towards a single, connected label management solution.
With more than a century of safe, effective usage, oral solid dose products are a proven pharmaceutical market mainstay.
In this special report, we explore how virtualization can provide significant advantages for deploying process control systems at pharmaceutical plants.
Supply chain collaboration is underleveraged in the pharmaceutical industry. Other sectors have put more focus on managing their supply chain, but most of pharma’s collaboration efforts still center on the commercial side.